%20(1).webp)
✕
1,500+ Reviews
from verified clinicians and learners →
Medicine doesn't stand still, and neither should the doctors practising it. Every year, new guidelines replace old ones, new diagnostic tools reshape assessment pathways, and patient expectations shift toward more specialised, more evidence-based care. For a working doctor, deciding where to invest limited CPD hours and course budget is one of the most consequential career decisions you'll make outside of the clinic itself.
This guide brings together the specialty courses that are genuinely reshaping clinical practice in 2026, from neurodevelopmental conditions like ADHD and autism, to dermatology, cardiology, palliative care, and beyond. Rather than a generic list of "top CPD providers," this is a practical breakdown of what each specialty pathway actually involves, who it's suited to, what it costs in time and money, and how to judge whether a given course is worth your signature.
Neurodevelopmental medicine gets particular attention here, because it's currently one of the fastest-growing and most underserved specialty areas in healthcare. Diagnosis waiting lists for ADHD and autism assessments stretch into years in many public health systems, and demand for suitably trained clinicians (doctors, psychiatrists, nurse prescribers, and pharmacists alike) is outpacing supply. Courses like those run by Global ADHD Network sit at the centre of that gap, and we'll look closely at what their Diagnosis and Management courses cover, alongside comparable options in other specialties.
By the end of this article, you should have a clear framework for evaluating any specialty course, not just the ones listed here, and a shortlist of where to start if neurodevelopmental medicine, or another in-demand specialty, is the direction you're considering.
The case for specialty training used to be framed almost entirely around career progression: a consultant post, a private clinic, a line on a CV. That's still true, but it's no longer the main driver. The bigger shift is patient demand outstripping the supply of clinicians qualified to meet it.
Take neurodevelopmental conditions as the clearest example. Referral rates for adult ADHD assessments have risen sharply across the UK, US, and much of Europe over the past five years, driven by a combination of greater public awareness, social media destigmatisation, and a backlog of adults who were missed as children. According to CDC data, roughly 6.0% of US adults (around 15.5 million people) now carry a current ADHD diagnosis, up from a previous estimate of 4.4%, and more than half of those diagnoses were made in adulthood rather than childhood. That's not a niche population. That's a mainstream clinical demand with nowhere near enough specialist capacity to meet it.
The same pattern shows up, to varying degrees, in other specialties. Dermatology waiting times in public systems regularly exceed recommended targets. Palliative care needs are climbing as populations age. Addiction medicine referrals have grown alongside prescription opioid and stimulant misuse. In each case, the bottleneck isn't a lack of interested doctors; it's a lack of doctors who have completed the specific, often practical, training required to assess and treat safely within that specialty.
This is where structured specialty courses earn their keep. Unlike a medical degree or core postgraduate training, which builds broad competence, a specialty course is designed to take a generalist and make them safely, demonstrably competent in one defined clinical area, usually within weeks rather than years. For a GP, psychiatrist, nurse prescriber, or pharmacist looking to either move into a growing field or simply deepen expertise in their existing one, that's an efficient way to expand what you can offer patients.
There's also a defensive angle worth naming directly: indemnity. Many medical defence organisations and insurers increasingly expect evidence of specific, accredited training before covering a clinician to practise in a specialty area, ADHD and autism assessment being a prominent example, where diagnostic tools like DIVA-5, ADI-R, and ADOS-2 require documented competency, not just clinical judgement. A course certificate isn't just a learning exercise; increasingly, it's the professional paperwork that lets you practise in that space at all.
Not all courses advertised as "specialist" or "CPD-certified" deliver the same value. Before comparing individual programmes, it helps to have a consistent checklist for judging any course you're considering, whether it's listed here or one you find independently.
Accreditation that actually means something. CPD certification is common, but the certifying body matters. A course accredited by a recognised CPD provider, aligned with a national guideline (such as NICE in the UK), or endorsed by a relevant royal college carries far more weight with employers, indemnity insurers, and regulators than a generic "certificate of completion."
Alignment with current clinical guidelines. Medicine changes. A dermatology course teaching outdated staging systems, or an ADHD course that hasn't been updated to reflect the latest NICE guideline (NG87) or DSM-5-TR criteria, will leave you certified but out of step with current best practice.
Practical, tool-specific training rather than theory alone. The most valuable specialty courses teach you to use the actual instruments you'll rely on in clinic (a structured diagnostic interview, a specific ultrasound protocol, a validated screening scale) with supervised practice, not just slides describing them.
Realistic case studies and breakout sessions. Courses that build in time for participants to work through real or realistic clinical scenarios, ask questions, and get feedback tend to translate into confidence in clinic far more reliably than lecture-only formats.
Transparent CPD hour allocation. If you're tracking hours for revalidation or a professional body's CPD scheme, the course should clearly state how many CPD hours or points it carries and how those map onto your appraisal requirements.
Post-course support. The best providers don't disappear once you've received your certificate. Look for ongoing access to resources, a referral or professional network, and a route to ask follow-up clinical questions as you start applying the training.
Reviews from clinicians who've actually completed it. Testimonials from doctors, nurses, psychologists, and pharmacists in similar roles to yours are a far better indicator of course quality than marketing copy. Global ADHD Network, for instance, publishes over 1,150 course reviews from clinicians across nursing, psychiatry, pharmacy, and general practice.
With that framework in mind, here's how the leading specialty course options stack up, starting with the area seeing the sharpest rise in demand.
ADHD assessment has moved from a niche subspecialty within child psychiatry to a mainstream clinical need spanning general practice, adult psychiatry, nursing, and pharmacy. The clinical challenge is that accurate adult ADHD diagnosis isn't intuitive; it requires structured use of validated tools, a solid grasp of differential diagnosis (ADHD symptoms overlap significantly with anxiety, depression, and trauma responses), and familiarity with frameworks like DSM-5 and the NICE NG87 guideline, which sets out that diagnosis should be specialist-led and typically supported by a structured interview.
This is the exact gap that Global ADHD Network's Diagnosis Course is built to close. The course is CPD-certified and designed specifically for healthcare professionals (doctors, nurses, psychologists, and pharmacists) who want in-depth, practical competence in diagnosing ADHD in adults using evidence-based methods. Core components include:
The course is delivered remotely as a full-day session and has been completed by more than 1,150 clinicians to date, with pricing starting from £795. It also fulfils part of the combined ADHD Specialist Certification pathway that many insurers now expect to see before covering a clinician for independent ADHD assessment work, which is worth noting given how often overlooked indemnity requirements catch clinicians out after they've already started building a caseload.
For any doctor considering a move into private ADHD assessment, or simply wanting to bring current, structured diagnostic skills into an NHS or public-system role, this is one of the highest-leverage specialty courses available right now, precisely because demand for competent assessors so significantly outstrips supply.
Diagnosis is only half of the clinical picture. Once a patient has a confirmed ADHD diagnosis, ongoing management (medication choice, titration, monitoring, and non-pharmacological support) requires its own distinct skill set, which is why Global ADHD Network runs diagnosis and management as separate, complementary courses.
The ADHD Management Course is built for clinicians who need practical competence in managing ADHD in adults, covering both pharmacological and non-pharmacological treatment pathways. Its curriculum includes:
Pricing reflects the level of the course and the audience it's designed for, starting at £1,200 for doctors and £1,500 for consultants and psychiatrists. Together, the Diagnosis and Management courses form what Global ADHD Network describes as the full ADHD Specialist Certification pathway, a combination increasingly recognised as fulfilling the standard NICE expects of practitioners qualified to both diagnose and treat ADHD independently.
For doctors already confident in general psychiatric or GP prescribing but new to stimulant medication specifically, this course closes a meaningful and clinically important gap, one that, left unaddressed, is one of the more common reasons clinicians hesitate to take on ADHD caseloads even when demand is there.
Autism and ADHD frequently co-occur, and referral pathways for both conditions increasingly overlap; a clinician trained only in one often finds themselves needing the other within the same caseload. Two instruments dominate rigorous autism assessment: the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2), both considered gold-standard tools internationally.
Global ADHD Network's ADI-R Training Course focuses on the structured parent/caregiver interview format, building fluency across the tool's three algorithm domains (social interaction, communication, and restricted/repetitive behaviours, or RRB) and training clinicians to interpret scores against both DSM-5 and ICD-11 diagnostic thresholds. Notably, the course also covers integrating ADI-R findings within a multi-modal assessment battery alongside ADOS-2, reflecting how autism diagnosis is rarely made on a single instrument alone in current best practice. Content is aligned with current NICE guidance on autism spectrum diagnosis.
For clinicians wanting observation-based competency specifically, the ADOS-2 Specialist Certification builds skills in the semi-structured, standardised observational assessment that complements interview-based tools like ADI-R. Because ADOS-2 relies on direct, structured observation of communication and social behaviour, training typically emphasises supervised practice and inter-rater reliability far more heavily than lecture content.
There's also a specific, related option worth flagging for clinicians working across both conditions: the Co-Occurring Autism & ADHD Course, which addresses the differential and combined diagnostic challenges that arise when both conditions are plausible explanations for a patient's presentation, a scenario that's more common in adult referrals than many clinicians initially expect.
For a doctor building a neurodevelopmental practice (whether inside the NHS, in private practice, or in an insurance-linked assessment role), holding certification across ADHD, ADI-R, and ADOS-2 substantially widens the referral types you can accept without needing to redirect patients elsewhere for a second, separate assessment pathway.
ADHD in women has historically been significantly under-diagnosed, largely because diagnostic criteria and early research were disproportionately based on hyperactive presentations more typical in boys, while inattentive presentations, more common in girls and women, were frequently missed or misattributed to anxiety, mood disorders, or simply personality. That diagnostic gap doesn't close on its own; it requires clinicians who are specifically trained to recognise how ADHD presents differently across sex and across the hormonal changes of puberty, pregnancy, and menopause.
Global ADHD Network's ADHD in Women course is built directly around this gap, covering how presentation differs from the more commonly recognised male-typical pattern, how hormonal fluctuations across the menstrual cycle, perimenopause, and menopause can mask or exacerbate symptoms, and how masking behaviours (a well-documented coping pattern where women consciously or unconsciously hide symptoms to meet social expectations) can delay diagnosis by years or even decades.
Given how much of the recent surge in adult ADHD diagnoses is occurring in women diagnosed later in life, this is a genuinely high-value, comparatively short specialist add-on for any clinician already working through the core Diagnosis and Management pathway. It's a strong example of a course that doesn't replace foundational training but meaningfully sharpens its accuracy for a specific, previously underserved patient population.
Dermatology remains one of the most consistently oversubscribed specialties for both training posts and patient referrals, and waiting times for routine dermatology appointments in many public health systems regularly extend well beyond recommended benchmarks. For GPs and physicians looking to build dermatology competence without pursuing a full specialist training pathway, several structured options exist.
Courses accredited through bodies like the British Association of Dermatologists and primary care-focused diploma programmes (such as the University of Cardiff's Diploma in Practical Dermatology) focus heavily on pattern recognition, dermoscopy for pigmented lesion assessment, and safe triage of suspicious lesions, arguably the highest-value skill for a generalist, given how much dermatology referral volume is driven by lesion checks rather than complex inflammatory disease. Practical, image-heavy courses with dermoscopy components tend to offer the best return for GPs, since dermoscopy training in particular has been shown to meaningfully improve diagnostic accuracy for melanoma versus benign naevi when used by appropriately trained non-specialists.
For doctors weighing dermatology against a neurodevelopmental pathway, the honest comparison is one of demand type: dermatology competence reduces referral volume and catches serious pathology earlier, while neurodevelopmental training (ADHD, autism) addresses a currently larger and faster-growing diagnostic backlog with comparatively fewer competing course providers.
Point-of-care ultrasound (POCUS) and focused echocardiography training has expanded rapidly across emergency medicine, acute medicine, general practice, and even primary care in recent years, driven by falling equipment costs and growing evidence that bedside ultrasound improves diagnostic speed for conditions like heart failure, pericardial effusion, and undifferentiated breathlessness.
Structured accreditation pathways through bodies such as the British Society of Echocardiography and focused ultrasound diploma programmes typically combine online theory modules with supervised scanning logbooks, requiring a minimum number of signed-off scans before certification is awarded, a more rigorous, competency-based model than most single-day CPD courses. This makes cardiology-focused ultrasound training a longer commitment than most neurodevelopmental or dermatology courses, often spanning months rather than a single day, but the resulting competency is correspondingly deeper.
For doctors in acute or emergency settings, focused echocardiography is arguably one of the highest-impact specialty skills available, given how directly it shortens time-to-diagnosis in unstable patients. For doctors in primary or outpatient care, the return is less immediate but still meaningful, particularly for early identification of valvular disease or heart failure in patients who might otherwise wait months for a formal echocardiogram referral.
As population ageing accelerates across most high-income countries, palliative and geriatric medicine training has shifted from a niche specialty interest to a near-universal requirement across general practice, hospital medicine, and community care. Structured courses accredited through bodies like the British Geriatrics Society and the Royal College of Physicians typically cover complex multimorbidity management, deprescribing in frail patients, advance care planning conversations, and symptom control in the last months of life.
What distinguishes strong courses in this space is an emphasis on communication skills alongside clinical content: conducting advance care planning discussions, managing family expectations, and navigating uncertainty are taught explicitly, not assumed. Given how emotionally demanding this specialty area can be, courses that include reflective practice components or peer discussion tend to be better regarded by past participants than those focused purely on clinical algorithms.
For doctors in general practice or hospital medicine, geriatric and palliative training compounds in value over a career, since an ageing patient population means this specialty's relevance only grows with time, arguably making it one of the more future-proof specialty investments on this list, even if it lacks the current acute demand spike seen in neurodevelopmental medicine.
Addiction medicine has seen renewed attention in the wake of rising prescription stimulant and opioid misuse, alongside the same forces driving the ADHD diagnosis surge, since untreated or misdiagnosed ADHD is itself a recognised risk factor for substance use disorders, creating meaningful clinical overlap between the two specialties. Structured training through bodies like the Royal College of Psychiatrists and dedicated addiction medicine certificate programmes covers assessment of dependency, safe prescribing and de-prescribing of controlled substances, and coordination with specialist addiction services.
For psychiatrists and GPs already holding ADHD Management certification, addiction medicine training is a particularly complementary next step, since the same population (adults with untreated or under-treated ADHD) carries elevated rates of comorbid substance use, and clinicians confident across both areas are better placed to manage complex, overlapping presentations without needing to refer patients through multiple separate specialist pathways.
Aesthetic medicine (covering treatments like botulinum toxin injection, dermal fillers, and non-surgical skin rejuvenation) has grown into a significant private-practice specialty, particularly for doctors looking to diversify income streams outside NHS or insurance-based work. Reputable training pathways are accredited through bodies such as the British College of Aesthetic Medicine, and typically combine theoretical modules on facial anatomy and complication management with supervised, hands-on injection practice.
This is a specialty area where regulatory scrutiny has increased substantially in recent years, following concerns about inadequately trained practitioners offering cosmetic procedures. Doctors considering this pathway should prioritise courses that emphasise complication recognition and management, vascular occlusion in particular, as heavily as injection technique itself, since safe complication management is increasingly what separates well-regarded practitioners from those facing regulatory or indemnity issues.
With this many options across specialties, the decision usually comes down to three practical questions rather than which course looks most impressive on paper.
What does your existing caseload actually need? A GP already fielding frequent adult ADHD referral requests gets more immediate value from the Diagnosis Course than from an aesthetic medicine qualification they'd need to build a client base for from scratch. Match training to demand you're already seeing, not demand you hope to attract.
What's the realistic time and cost commitment, and does it fit your current role? Single-day CPD courses (like most neurodevelopmental and dermatology options) fit around existing clinical commitments far more easily than multi-month logbook-based pathways like echocardiography accreditation. Be honest about how much protected study time you actually have.
Does the certification unlock something concrete, such as indemnity cover, a referral pathway, or a new clinic offering, or is it purely developmental? Both are valid reasons to train, but they should shape which course you pick. If you need to start seeing ADHD assessment patients within a defined indemnity framework, the combined Diagnosis plus Management pathway is a clearer, faster route than piecing together less formal CPD content from multiple sources.
It's also worth speaking directly to a course provider before enrolling. Global ADHD Network, for example, explicitly invites enquiries from clinicians unsure which course best matches their current scope of practice, a useful step before committing course fees, particularly for the higher-cost Management and Specialist Certification pathways.
For UK-based doctors, every specialty course decision sits within the broader framework of GMC revalidation. The GMC requires doctors to undertake continuing professional development every year, tailored to their actual scope of practice, with CPD activity reviewed and discussed at annual appraisal. Most royal colleges and employers recommend a minimum of roughly 50 CPD credits per year, working out to around 250 points across a standard five-year revalidation cycle.
This matters practically in two ways. First, CPD hours need to be genuinely relevant to your current or emerging practice: a course chosen purely because it's cheap or convenient, without connection to your actual clinical work, is weaker evidence at appraisal than one that clearly maps onto a defined area of your practice. Second, the number of CPD hours a course carries should be stated transparently upfront; Global ADHD Network's certification pathway, for instance, provides up to 16 CPD-certified hours across its combined Diagnosis and Management courses, giving clinicians a clear, documentable contribution toward their annual requirement.
Accreditation also intersects directly with indemnity. Medical defence organisations increasingly ask specific questions about training completed before extending or confirming cover for specialty work, again most visibly in ADHD and autism assessment, where use of structured tools like DIVA-5, ADI-R, and ADOS-2 is expected to be backed by documented, course-verified competency rather than self-taught familiarity. Choosing accredited, well-documented courses isn't just about learning quality; it's part of protecting your ability to practise in that specialty at all.
Beyond clinical and regulatory considerations, specialty certification has a direct, measurable effect on career options and earning potential, though the size of that effect varies considerably by specialty and setting.
In neurodevelopmental medicine specifically, the combination of high patient demand and a limited pool of certified assessors has created strong private practice opportunities for doctors, psychiatrists, and appropriately qualified nurse prescribers. Doctors who complete the Diagnosis and Management pathway frequently move into private ADHD assessment clinics, either independently or through platforms connecting certified clinicians with patients, an option made more accessible by Global ADHD Network's own referrals network and careers board, which connect trained clinicians with relevant opportunities.
Aesthetic medicine and dermatology similarly offer strong private-practice earning potential, though typically require a larger upfront investment in equipment, premises, or insurance before that potential is realised. Cardiology-focused ultrasound and palliative/geriatric certification tend to have a less dramatic direct financial impact but a more consistent, long-term career value, since they're broadly applicable within salaried NHS and hospital-system roles rather than dependent on building an independent patient base.
The general pattern worth noting: specialties with the largest current gap between demand and trained supply (neurodevelopmental assessment being the clearest current example) tend to offer the fastest return on a course investment, both in terms of how quickly a newly certified clinician can start seeing relevant patients and in terms of fee levels those assessments can command in private practice.
Do I need to be a psychiatrist to take an ADHD diagnosis or management course?No. Courses like Global ADHD Network's Diagnosis and Management courses are explicitly designed for a mixed audience of doctors, nurses, psychologists, and pharmacists, reflecting how ADHD assessment and prescribing responsibilities are increasingly shared across these roles rather than confined to psychiatry alone.
How long does it take to complete a specialty course like the ADHD Diagnosis Course?Most neurodevelopmental courses in this space, including the Diagnosis Course, are delivered as a single full-day session, making them considerably faster to complete than logbook-based pathways like echocardiography accreditation, which can take several months.
Is one specialty course enough, or should I combine several?It depends on your caseload. For neurodevelopmental medicine specifically, combining the Diagnosis Course, Management Course, and a co-occurring conditions course such as ADI-R or the Co-Occurring Autism & ADHD Course gives a meaningfully broader referral scope than any single course alone.
Will a specialty course affect my indemnity cover?It can, in a positive direction. Many indemnity providers look for documented, accredited training before confirming cover for specialty work, particularly in areas involving structured diagnostic tools or controlled medication prescribing. Always confirm requirements with your specific indemnity provider before relying on a course certificate alone.
How do I know if a course is properly accredited?Check for CPD certification from a recognised body, clear alignment with current national guidelines (NICE, in the UK, for most clinical specialties), and transparency about CPD hours awarded. If a provider can't clearly answer how their course maps onto your revalidation or appraisal requirements, treat that as a warning sign.
The specialty courses that offer the strongest return right now share a common thread: they sit at the intersection of genuine patient demand and a real shortage of properly trained clinicians. Neurodevelopmental medicine (ADHD assessment, ADHD management, and co-occurring autism assessment) currently sits closer to that intersection than almost any other specialty area, which is exactly why it's given the deepest treatment in this guide.
If that's the direction you're considering, the most efficient starting point is Global ADHD Network's combined Diagnosis and Management pathway, built specifically for doctors, nurses, psychologists, and pharmacists who want to move into ADHD assessment and treatment with structured, evidence-based, CPD-certified training behind them. From there, courses like ADHD in Women, ADI-R, and ADOS-2 let you build out a broader neurodevelopmental practice as your caseload and confidence grow.
Whichever specialty you choose, the underlying principle holds: pick training that matches demand you're already seeing, is backed by real accreditation, and gives you documentable, defensible competency, not just a certificate for the wall.
Sources referenced: NICE Guideline NG87, NICE Guideline CG170 on Autism, CDC ADHD data, GMC guidance on CPD, British Association of Dermatologists, British Society of Echocardiography, British Geriatrics Society, Royal College of Physicians, Royal College of Psychiatrists, British College of Aesthetic Medicine.
